WO2002003061A3 - Verfahren zur identifizierung von die für behandlung von virusinfektionen geeigneten stoffen - Google Patents
Verfahren zur identifizierung von die für behandlung von virusinfektionen geeigneten stoffen Download PDFInfo
- Publication number
- WO2002003061A3 WO2002003061A3 PCT/EP2001/007781 EP0107781W WO0203061A3 WO 2002003061 A3 WO2002003061 A3 WO 2002003061A3 EP 0107781 W EP0107781 W EP 0107781W WO 0203061 A3 WO0203061 A3 WO 0203061A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- virus infections
- treating virus
- identifying substances
- substances
- relates
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/533—Production of labelled immunochemicals with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/332,146 US20040101824A1 (en) | 2000-07-06 | 2001-07-06 | Method for identifying substances which are suitable to be used as medicaments for the treating virus infections or for testing the effectiveness of such substances |
CA002414786A CA2414786A1 (en) | 2000-07-06 | 2001-07-06 | Method for identifying substances which are suitable to be used for treating virus infections |
AU2001277528A AU2001277528A1 (en) | 2000-07-06 | 2001-07-06 | Method for identifying substances which are suitable to be used for treating virus infections |
EP01955335A EP1297183A2 (de) | 2000-07-06 | 2001-07-06 | Verhahren zur identifizierung von für die behandlung von virusinfektionen geeigneten stoffen |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10032859A DE10032859A1 (de) | 2000-07-06 | 2000-07-06 | Verfahren zum Erfassen von Viren |
DE10032859.8 | 2000-07-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002003061A2 WO2002003061A2 (de) | 2002-01-10 |
WO2002003061A3 true WO2002003061A3 (de) | 2002-08-22 |
Family
ID=7648000
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2001/007781 WO2002003061A2 (de) | 2000-07-06 | 2001-07-06 | Verfahren zur identifizierung von die für behandlung von virusinfektionen geeigneten stoffen |
Country Status (6)
Country | Link |
---|---|
US (1) | US20040101824A1 (de) |
EP (1) | EP1297183A2 (de) |
AU (1) | AU2001277528A1 (de) |
CA (1) | CA2414786A1 (de) |
DE (1) | DE10032859A1 (de) |
WO (1) | WO2002003061A2 (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3461836A1 (de) | 2017-09-28 | 2019-04-03 | Universität zu Köln | Mutierte kapsid proteine von adeno-assoziierten viren zur chemischen kopplung von liganden, nanopartikeln oder medikamenten über thioetherbindung und methode zu deren herstellung |
CN111537480B (zh) * | 2020-04-26 | 2023-05-02 | 中央民族大学 | 基于单分子全内反射荧光成像技术的病毒快速检测方法 |
-
2000
- 2000-07-06 DE DE10032859A patent/DE10032859A1/de not_active Withdrawn
-
2001
- 2001-07-06 AU AU2001277528A patent/AU2001277528A1/en not_active Abandoned
- 2001-07-06 US US10/332,146 patent/US20040101824A1/en not_active Abandoned
- 2001-07-06 EP EP01955335A patent/EP1297183A2/de not_active Withdrawn
- 2001-07-06 WO PCT/EP2001/007781 patent/WO2002003061A2/de not_active Application Discontinuation
- 2001-07-06 CA CA002414786A patent/CA2414786A1/en not_active Abandoned
Non-Patent Citations (5)
Title |
---|
BARTLETT JEFFREY S ET AL: "Fluorescent viral vectors: A new technique for the pharmacological analysis of gene therapy.", NATURE MEDICINE, vol. 4, no. 5, May 1998 (1998-05-01), pages 635 - 637, XP002201152, ISSN: 1078-8956 * |
BARTLETT JEFFREY S ET AL: "Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors", JOURNAL OF VIROLOGY, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 74, no. 6, March 2000 (2000-03-01), pages 2777 - 2785, XP002154341, ISSN: 0022-538X * |
LEOPOLD PHILIP L ET AL: "Fluorescent virions: Dynamic tracking of the pathway of adenoviral gene transfer vectors in living cells.", HUMAN GENE THERAPY, vol. 9, no. 3, 10 February 1998 (1998-02-10), pages 367 - 378, XP008004167, ISSN: 1043-0342 * |
SEISENBERGER GEORG ET AL: "Real-time single-molecule imaging of the infection pathway of an adeno-associated virus.", SCIENCE (WASHINGTON D C), vol. 294, no. 5548, 30 November 2001 (2001-11-30), pages 1929 - 1932, XP002201153, ISSN: 0036-8075 * |
WEISS SHIMON: "Fluorescence spectroscopy of single biomolecules", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,, US, vol. 283, no. 5408, 12 March 1999 (1999-03-12), pages 1676 - 1683, XP002171250, ISSN: 0036-8075 * |
Also Published As
Publication number | Publication date |
---|---|
AU2001277528A1 (en) | 2002-01-14 |
EP1297183A2 (de) | 2003-04-02 |
WO2002003061A2 (de) | 2002-01-10 |
CA2414786A1 (en) | 2003-01-03 |
DE10032859A1 (de) | 2002-01-17 |
US20040101824A1 (en) | 2004-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1999051748A3 (en) | Fusion proteins of mycobacterium tuberculosis antigens and their uses | |
WO2002058638A3 (en) | Serpin drugs for treatment of hiv infection and method of use thereof | |
BRPI0412845A (pt) | herpes-vìrus, uso de um vìrus, composição farmacêutica, e, método de tratamento de um tumor em um indivìduo em necessidade do mesmo | |
EP1128832A4 (de) | Verbindungen, zusammenstellungen und methoden zur phophylaxe und behandlung von viralen infektionen und damit verbundenen erkrankungen | |
NO20050795L (no) | Forbindelser, blandinger og fremgangsmater for utnyttelse av samme | |
ATE266723T1 (de) | Lösung die chaotropische mittel enthält und verwendung dieser lösung in verfahren zur isolierung von dna, rna und proteinen | |
WO2001098317A3 (en) | Alpha-glycosylceramides for treating bacterial and fungal infections | |
WO2002092006A3 (en) | Nucleic acid-based compounds and methods of use thereof | |
DE60137337D1 (de) | Vorbeugende und therapeutsche monoklonale antikörper gegen vacciniavirusantigene | |
WO2001090331A3 (en) | C1 bacteriophage lytic system | |
WO2002006513A3 (en) | A method for treating herpes viruses | |
WO2002040668A3 (de) | Proteine und den proteinen zugrundeliegende dna-sequenzen mit funktion bei entzündungsereignissen | |
PT932613E (pt) | Expressao de bloqueio de factoes de virulencia em s. aureus | |
WO2004085682A3 (de) | Caspase inhibitoren, insbesondere von caspase-3, zur behandlung von influenza | |
WO2005092924A3 (en) | Rab9a, rab11a, and modulators thereof related to infectious disease | |
WO2002030964A3 (en) | Comparative ligand mapping from mhc positive cells | |
DE60132443D1 (de) | In lebenden zielzellen | |
WO2001008672A3 (en) | Glucamine compounds for treating hepatitis virus infections | |
WO2002003061A3 (de) | Verfahren zur identifizierung von die für behandlung von virusinfektionen geeigneten stoffen | |
DE60032915D1 (de) | Gallium komplexe von 3-hydroxy-4-pyronen zur behandlung von durch intrazelluläre prokaryoten, dns- und retro-viren verursachten infektionen | |
AP2000001937A0 (en) | Method for identifying chemical active agents and active agents for inhibiting the 1-desoxy-d-xylulose-5-phosphate biosynthetic pathway. | |
WO2003059262A3 (en) | Method and composition for treating and preventing hiv infection and aids | |
AU4204700A (en) | Compounds and methods for the diagnosis and treatment of (b. microti) infection | |
WO2003093431A3 (en) | Ablated slam-dependent entry | |
ZA200205470B (en) | Virus strains for the oncolytic treatment of cancer. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2414786 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001955335 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2001955335 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10332146 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2001955335 Country of ref document: EP |